SCHEMBL100775

SCHEMBL100775

NC(Cc1ccccc1)=NO

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.57
CTBP2 P56545 1/20 0.52
LMNA P02545 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
KDM1A O60341 1/20 0.47
CES2 O00748 1/20 0.46
CES1 P23141 1/20 0.46
AKR1B1 P15121 1/20 0.46
ALDH1A1 P00352 3/20 0.46
GAA P10253 1/20 0.46
HTT P42858 1/20 0.46
KMT2A Q03164 1/20 0.46
MAPT P10636 1/20 0.44
GRIN1 Q05586 2/20 0.44
GRIN2B Q13224 2/20 0.44
CTSL P07711 1/20 0.43
KDM4E B2RXH2 1/20 0.42
HPGD P15428 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HTR3A P46098 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL563549 1.00 HIF1A (0.57) HIF1ACTBP2LMNASMN1; SMN2KDM1A
SCHEMBL100774 1.00 HIF1A (0.57) HIF1ACTBP2LMNASMN1; SMN2KDM1A
SCHEMBL17730475 0.92 SLC22A2 (0.53) HIF1ACTBP2LMNASMN1; SMN2KDM1A
SCHEMBL21096339 0.87 LMNA (0.53) HIF1ACTBP2LMNASMN1; SMN2KDM1A
SCHEMBL28911258 0.87 LMNA (0.53) HIF1ACTBP2LMNASMN1; SMN2KDM1A
SCHEMBL5955216 0.81 HIF1A (0.57) HIF1ACTBP2LMNASMN1; SMN2CES2
SCHEMBL5955218 0.81 HIF1A (0.57) HIF1ACTBP2LMNASMN1; SMN2CES2
SCHEMBL10397502 0.80 NPC1 (0.57) ALDH1A1
SCHEMBL10397503 0.80 NPC1 (0.57) ALDH1A1
SCHEMBL21824482 0.80 MEN1 (0.44) HIF1ALMNASMN1; SMN2ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 227 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2207872-A1 NOVEL NITRILE AND AMIDOXIME COMPOUNDS AND METHODS OF PREPARATION EKC Technology, INC. (US) 2010-07-21 EP claimed
US-20090130849-A1 CHEMICAL MECHANICAL POLISHING AND WAFER CLEANING COMPOSITION COMPRISING AMIDOXIME COMPOUNDS AND ASSOCIATED METHOD FOR USE EKC TECHNOLOGY, INC. 2009-05-21 US claimed
WO-2009058274-A1 CHEMICAL MECHANICAL POLISHING AND WAFER CLEANING COMPOSITION COMPRISING AMIDOXIME COMPOUNDS AND ASSOCIATED METHOD FOR USE EKC TECHNOLOGY, INC. (US) 2009-05-07 WO claimed
WO-2009058277-A1 NOVEL NITRILE AND AMIDOXIME COMPOUNDS AND METHODS OF PREPARATION EKC TECHNOLOGY, INC. (US) 2009-05-07 WO claimed
US-20090111965-A1 NOVEL NITRILE AND AMIDOXIME COMPOUNDS AND METHODS OF PREPARATION EKC TECHNOLOGY, INC. 2009-04-30 US claimed
US-5821267-A MODULATING THE INDUCIBLE ISOFORM OVER THE CONSTITUTIVE; HYPERTENSIVE, ANTIARTHRITIC AND DIABETIC AGENTS; THERAPY WITH CYTOKINES; TOXIC AND SEPTIC SHOCK G.D. SEARLE & CO. (US) 1998-10-13 US claimed
EP-0724435-A1 AMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1996-08-07 EP claimed
WO-1995011014-A1 AMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1995-04-27 WO claimed
EP-4709725-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF Progentos Therapeutics, Inc. (US) 2026-03-18 EP disclosed
US-20260042731-A1 (2,4-DICHLOROPHENOXY)ACETIC ACID ANALOGS CORTEVA AGRISCIENCE LLC (US) 2026-02-12 US disclosed
US-20250388601-A1 Compounds, Compositions and Methods DENALI THERAPEUTICS INC. (US) 2025-12-25 US disclosed
US-12435181-B2 Formulations capable of reacting with or removal of molecular oxygen LI SHENSHEN (US) 2025-10-07 US disclosed
US-12358928-B2 Compounds, compositions and methods DENALI THERAPEUTICS INC. (US) 2025-07-15 US disclosed
CN-119731146-A (2, 4-Dichlorophenoxy) acetic acid analogues 科迪华农业科技有限责任公司 2025-03-28 CN disclosed
WO-1984004676-A1 POLYHYDROXYBENZOIC ACID DERIVATIVES RIET BARTHOLOMEUS VAN T 1984-12-06 WO disclosed
EP-0092706-A1 Oxadiazole derivatives NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1983-11-02 EP disclosed
US-4308399-A O-(3-Amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT. (HU) 1981-12-29 US disclosed
US-4187220-A New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA R.T. (HU) 1980-02-05 US disclosed
US-4134985-A 5-CYCLOPROPANE CARBOXYLATE OXADIAZOLES AS INSECTICIDES AND ACARICIDES STAUFFER CHEMICAL COMPANY (US) 1979-01-16 US disclosed
US-3956498-A SYNERGISTIC, INSECTICIDES S. C. JOHNSON & SON, INC. (US) 1976-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250388601-A1 Compounds, Compositions and Methods AURKC, WEE2, ERBB2 HIF1A 2807/4885CTBP2 3381/4885LMNA 581/4885
US-12358928-B2 Compounds, compositions and methods PIK3CA, PLK1, PIK3CB HIF1A 3501/4885CTBP2 2719/4885LMNA 1620/4885
US-20260042731-A1 (2,4-DICHLOROPHENOXY)ACETIC ACID ANALOGS DDT, AADAC, HACL2 HIF1A 4386/4885CTBP2 3069/4885LMNA 1738/4885
US-20090111965-A1 NOVEL NITRILE AND AMIDOXIME COMPOUNDS AND METHODS OF PREPARATION GNMT, NIT2, NNMT HIF1A 2917/4885CTBP2 3759/4885LMNA 614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.